Perspectives in Nanomedicine-Based Research Towards Cancer Therapies
Nanomedicine is focused on the development of submicrometer carriers designed for improving the biodistribution of systemically administered drugs. Nanoparticles have been exploited for immunoassays, immunohistochemistry, cancer diagnostics, bioseparation of specific cell populations, and cellular imaging. Public awareness on the use of these novel therapeutic approaches is increasing due to the exponential boom of nanotechnologies in the latest years. With respect to cancer therapy, several tumour-targeted nanomedicines have been evaluated over the years, and there is a clear evidence for substantial improvement of the therapeutic index of antineoplastics. The present review addresses the most relevant targeting strategies, discussing the major public awareness, therapeutic advances and future directions in the development of tumour-targeted nanomedicines.
No Supplementary Data
No Article Media
Document Type: Research Article
Publication date: 01 April 2011
More about this publication?
- Current Nanoscience publishes authoritative reviews and original research reports, written by experts in the field on all the most recent advances in nanoscience and nanotechnology. All aspects of the field are represented including nano- structures, synthesis, properties, assembly and devices. Applications of nanoscience in biotechnology, medicine, pharmaceuticals, physics, material science and electronics are also covered. The journal is essential to all involved in nanoscience and its applied areas.